BioTalk Unzipped

Dr. Tomas Helikar, a leading researcher in bioinformatics and systems biology, delves into groundbreaking work on developing a personalized immune digital twin, which aims to revolutionize the understanding and treatment of immune-related diseases.  Chapters 00:00 Introduction to BioTalk Unzipped 01:50 Meet Dr. Tomas Helikar 04:34 The Journey into Systems Biology 10:03 Understanding Digital Twins in Immunology 14:19 The Importance of Personalized Medicine 17:20 Digital Twin Research Funding and Its Impact 18:38 The Role of Digital Twins in Disease Management 21:11 Digital Twin Efforts for Organ Transplants 24:05 Computational Challenges in Modeling 26:36 Mathematical Models in Biological Research 28:11 - NEW NEWS! - Twist Joins Absci in AI Antibody Collaboration How to reach us: Tomas Helikar  https://www.linkedin.com/in/tomashelikar/ [https://www.linkedin.com/in/tomashelikar/]  X - https://x.com/tomashelikar [https://x.com/tomashelikar]  Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/ [https://www.linkedin.com/in/chadbriscoe/]  Celerion - https://www.celerion.com/ [https://www.celerion.com/]   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/ [https://www.linkedin.com/in/gregoryaustin1/]  ECI - https://eci-rx.com [https://eci-rx.com] /  Charity Mentioned: https://saintpeterlincoln.com/school [https://saintpeterlincoln.com/school]  FOLLOW ► LinkedIn: https://www.linkedin.com/company/biotalk-unzipped [https://www.linkedin.com/company/biotalk-unzipped] Twitter: https://x.com/BiotalkUnzipped [https://x.com/BiotalkUnzipped] Instagram: https://www.instagram.com/biotalkunzipped/ [https://www.instagram.com/biotalkunzipped/]  Takeaways * Dr. Helikar's research focuses on the immune system's network and disease. * Systems biology integrates computer science and biology for better understanding. * Digital twins can provide personalized models for immune system analysis. * Your digital twin model could tell you how you might respond to a particular disease and if you really need to go to the hospital. * The immune digital twin reflects an individual's unique immune baseline. * Research funding is crucial for advancing innovative medical technologies. * Personalized medicine can improve public health outcomes significantly. * Computational power is essential for processing complex biological data. * Mathematical models are vital for simulating biological processes. * Digital twins can enhance drug discovery and clinical trial efficiency. Sound Bites "The immune system is a network of networks." “Each of our immune system baselines are different.” "We need to build out this multi-scale model." New News Story:  * Supplier-Turned-Partner: Twist Joins Absci in AI Antibody Collaboration * https://www.genengnews.com/topics/drug-discovery/supplier-turned-partner-twist-joins-absci-in-ai-antibody-collaboration/ [https://www.genengnews.com/topics/drug-discovery/supplier-turned-partner-twist-joins-absci-in-ai-antibody-collaboration/] Image Credits * Signal Transduction, www.scientificanimations.com - http://www.scientificanimations.com/wiki-images/ [http://www.scientificanimations.com/wiki-images/] * Computational Model, https://computationstructures.org/notes/models/notes.html [https://computationstructures.org/notes/models/notes.html]  * Holland computer center, https://newsroom.unl.edu/announce/cse/16380/90600 [https://newsroom.unl.edu/announce/cse/16380/90600]  * https://news.unl.edu/article/husker-football-game-day-information-announced-for-2023 [https://news.unl.edu/article/husker-football-game-day-information-announced-for-2023] * https://hcc.unl.edu/office-locations [https://hcc.unl.edu/office-locations]

Dr. Mark Arnold, a distinguished bioanalytical thought leader with an impressive track record in supporting drug development programs. Mark is the Owner and Principal at Bioanalytical Solution Integration, where he provides strategic counsel on complex bioanalytical assays and regulatory compliance. With over 35  years of experience, including leadership roles at BMS and Labcorp, Mark has become a key figure in the biotech and pharma industries. He is also an AAPS Fellow and a founder of the Global Bioanalysis Consortium.  01:05 - Career Reflections and Contributions to Drug Development 05:28 - Understanding the Integration of Drug Development 09:30 - What Would You Change? Embracing Career Risks in Pharma 11:32 - Navigating Career Paths: Small vs. Large Companies 16:09 - NEW NEWS! - Can Electrical Fields Disrupt Cancer? 23:28 - The Role of AI in Drug Development 31:13 - Encouraging Innovation in a Regulated Industry Follow Mark, Chad and Gregory: Please donate to: Samaritan’s Purse https://www.samaritanspurse.org/ [https://www.samaritanspurse.org/]  Mark Arnold - https://www.linkedin.com/in/markearnoldphd/ [https://www.linkedin.com/in/markearnoldphd/]  Blog - https://bioanalysisandbiomarkers.blogspot.com/ [https://bioanalysisandbiomarkers.blogspot.com/]    Dr. Chad Briscoe - https://www.linkedin.com/in/chadbriscoe/ [https://www.linkedin.com/in/chadbriscoe/]  Celerion - https://www.celerion.com/ [https://www.celerion.com/]   Gregory Austin - https://www.linkedin.com/in/gregoryaustin1/ [https://www.linkedin.com/in/gregoryaustin1/]  ECI - https://eci-rx.com [https://eci-rx.com] /  BioTalk Unzipped on LinkedIn - https://www.linkedin.com/company/biotalk-unzipped/ [https://www.linkedin.com/company/biotalk-unzipped/]  New News Story:  * Novocure wins FDA approval for electric field device in lung cancer * https://www.biopharmadive.com/news/novocure-fda-lung-cancer-approval-optune-lua-tumor-treating-field/729997 [https://www.biopharmadive.com/news/novocure-fda-lung-cancer-approval-optune-lua-tumor-treating-field/729997] Two articles on finding 1000’s of dark matter RNA viruses:   * https://www.fiercebiotech.com/research/deep-learning-ai-model-scans-dark-matter-genomic-data-and-finds-70000-never-seen-rna [https://www.fiercebiotech.com/research/deep-learning-ai-model-scans-dark-matter-genomic-data-and-finds-70000-never-seen-rna] * https://www.nature.com/articles/d41586-024-03320-6 [https://www.nature.com/articles/d41586-024-03320-6] Image Credits * Novocure images courtesy of Novocure: www.novocure.com [http://www.novocure.com]

In this episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Dr. Mark Arnold, a distinguished bioanalytical thought leader. They discuss the impact of recent FDA regulations on drug development, the importance of community support through the Samaritan Purse charity, especially on recent hurricane victims, and the exciting advancements in RNA editing technologies. The conversation highlights the collaborative nature of the pharmaceutical industry and the drive behind bioanalytical work, emphasizing the ultimate goal of delivering effective therapies to patients.  Chapters 00:00 Introduction to BioTalk Unzipped at AAPS PharmSci 360 03:45 Samaritan's Purse Charity and Community Impact 05:16 Most impactful talk at AAPS? 11:50 Comparative Analysis of FDA and EU Regulations 17:37 The Drive Behind Bioanalytical Work 22:24 NEW NEWS! - Innovations in RNA Editing and Bioanalysis Takeaways * The FDA's new rules on lab-developed tests could delay biomarker utilization in clinical trials. * Community support through charities like Samaritan's Purse is crucial during crises. * The importance of collaboration in advancing drug development and bioanalytical methods. * Innovations in RNA editing present new bioanalytical challenges. * The drive to help patients is a key motivator for professionals in the field. * Sound Bites * "I worked on that drug and there's a clear benefit." * "It's getting that new therapy to a patient." * "This is going to change and potentially delay biomarkers." * New News Story:  * Wave sees RNA editing validation in early trial results ◦https://www.biopharmadive.com/news/wave-rna-editing-aatd-first-trial-data/729981/ [https://www.biopharmadive.com/news/wave-rna-editing-aatd-first-trial-data/729981/]  How to reach us: Please donate to: Samaritan’s Purse https://www.samaritanspurse.org/ [https://www.samaritanspurse.org/]  Mark Arnold https://www.linkedin.com/in/markearnoldphd/ [https://www.linkedin.com/in/markearnoldphd/]  Blog - https://bioanalysisandbiomarkers.blogspot.com/ [https://bioanalysisandbiomarkers.blogspot.com/]    Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/ [https://www.linkedin.com/in/chadbriscoe/]  Celerion - https://www.celerion.com/ [https://www.celerion.com/]   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/ [https://www.linkedin.com/in/gregoryaustin1/]  ECI - https://eci-rx.com [https://eci-rx.com/] /  Image Credits * AAPS

EP-23. In the second half of this compelling conversation on BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe continue their deep dive with Scott Ogle, CEO of TruLab. They explore the surprising parallels between the banking and pharma industries, the game-changing role of digital twinning in clinical trials, and the biotech funding landscape. Scott also shares his thoughts on leadership, mentorship, and the impact of the Inflation Reduction Act on pharma innovation. This episode offers listeners valuable insights into the future of drug development and the challenges of balancing professional and personal life in a fast-paced industry. Chapters 1:09 - Comparison of the Banking Industry to the Pharma Industry 5:18 - Data Integrity, Same For Decentralized Trials? 8:33 - Biotech Funding Trends 11:18 - NEW NEWS! – Digital Twinning in Clinical Trials 16:15 - What Advice Would You Give to Your Younger Self? 20:57 - Mentorship and Its Impact, How it Shaped Scott 23:45 - Balancing Work and Personal Life 24:32 - The Inflation Reduction Act and Innovation Takeaways * The regulatory environment in pharma can slow down innovation. * Digital twinning in clinical trials could revolutionize drug development. * Family influences play a significant role in shaping business perspectives. * The need for a strong company culture to maintain values during growth. * Biotech funding trends are influenced by macroeconomic factors like interest rates. * The importance of mentorship in professional development. Sound Bites * “The similarities between the banking industry and the pharma industry is eerily similar.” * “Quality is really what we do.” * “Being quality is core to software.” * “It’s really clear people care more about their money than they do their healthcare.” * “Biotech and large pharma seem to balance each other out.” * “The career for you is at the intersection of what you are good at and what you like to do.”  * “If you’re good at something and you like to do it, it fuels your energy to keep getting better.” * “Enjoy the impact in what you’re doing and accomplishing!” New News Story:  * Digital “Twinning”: Clinical Trials Powered by AI * https://www.sanofi.com/en/magazine/our-science/digital-twinning-clinical-trials-ai [https://www.sanofi.com/en/magazine/our-science/digital-twinning-clinical-trials-ai]   How to reach us: Scott Ogle https://www.linkedin.com/in/scott-ogle/ [https://www.linkedin.com/in/scott-ogle/]  TruLab - https://trulab.com/ [https://trulab.com/]    Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/ [https://www.linkedin.com/in/chadbriscoe/]  Celerion - https://www.celerion.com/ [https://www.celerion.com/]   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/ [https://www.linkedin.com/in/gregoryaustin1/]  ECI - https://eci-rx.com [https://eci-rx.com] /  Image Credits Digital Twinning - Credit Getty Images Simulation - Credit: andrush / Adobe Stock Tomáš Helikar - https://www.linkedin.com/in/tomashelikar/ [https://www.linkedin.com/in/tomashelikar/]  Nebraska Swan computer - https://newsroom.unl.edu/announce/cse/16380/90600 [https://newsroom.unl.edu/announce/cse/16380/90600] Brian Hamilton - https://inmatestoentrepreneurs.org/board/brian-hamilton/ [https://inmatestoentrepreneurs.org/board/brian-hamilton/]

Summary In this 22nd episode of BioTalk Unzipped, host Gregory Austin and co-host Chad Briscoe engage with Scott Ogle, CEO of TrueLab, discussing his journey from finance to the pharmaceutical industry, the impact of personal experiences on innovation, and the importance of technology in clinical trials. They explore how to hire the best employees in this climate, the significance of company culture, and the influence of family on business perspectives.  Chapters 00:00 Introduction to BioTalk Unzipped 03:15 The Impact of Personal Experience on Innovation 08:47 TruLab's Technology and Its Role in Clinical Trials 14:33 The Importance of Sample Management and the Genesis of TruLab 20:33 NEW NEWS! – The Future of Cancer Treatments 23:34 Hiring Patterns and the value of Company Culture Takeaways * Scott Ogle's personal experience with his father's illness inspired the creation of TruLab. * TruLab focuses on eliminating inefficiencies in clinical trial sample management. * The importance of having fun in one's career for productivity and happiness. * Hiring for energy and cultural fit is crucial for company success. * More young people out of college actually prefer working in the office, so it’s a hiring advantage. Sound Bites * “Entrepreneurs get excited about their solution but can forget about what problem they’re solving.” * "We need to iterate on technology in clinical trials." * “20-25% of biological samples get tossed out.” * "You can't coach energy in a candidate." * “Company values. Senior leadership must beat it like a drum.” * “Interviewing candidates on company values is your North Star.” * “Go by what people do, not by what they say.”  * “Hallway meetings, that’s where stuff gets done.” New News Story:  * ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells * https://www.nature.com/articles/s43018-024-00821-1 [https://www.nature.com/articles/s43018-024-00821-1] How to reach us: Scott Ogle https://www.linkedin.com/in/scott-ogle/ [https://www.linkedin.com/in/scott-ogle/]  TruLab - https://trulab.com/ [https://trulab.com/]  Leukemia & Lymphoma Society - https://www.lls.org/ [https://www.lls.org/]    Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/ [https://www.linkedin.com/in/chadbriscoe/]  Celerion - https://www.celerion.com/ [https://www.celerion.com/]   Gregory Austin https://www.linkedin.com/in/gregoryaustin1/ [https://www.linkedin.com/in/gregoryaustin1/]  ECI - https://eci-rx.com [https://eci-rx.com] /  Keywords: Scott Ogle, TruLab, clinical trial technology, biotech innovation, sample management in clinical trials, hiring for company culture, company values in leadership, finance to pharma journey, revolutionizing clinical trials, impact of personal experience on innovation, biotechnology leadership, clinical trial inefficiencies, cancer treatment news, digital transformation in pharma, family influence in business, company culture in biotech, pharmaceutical funding challenges, ISB 2001 trispecific T cell engager. Tags: #ScottOgle, #TruLab, #ClinicalTrials, #Biotech, #PharmaInnovation, #Sample Management, #Company Culture, #Hiring Tips, #BiotechLeadership, #PharmaTechnology, #CancerTreatment, #PersonalInnovation, #BiotechFunding, #LeadershipInPharma, #BusinessLeadership, #PharmaceuticalIndustry.